banner add

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

from NYT > Health https://ift.tt/HO1FV4S
via IFTTT

No comments

What Role Did Ketamine Play in Cornell’s Alleged Rape Case?

Ketamine a short-acting anesthetic that can have hallucinogenic effects. It is becoming more easily available, and some experts fear misuse ...

Theme images by PLAINVIEW. Powered by Blogger.